Liberty Star Uranium & Metals (LBSR) 10-Q 20 Sep 21 2022 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jul. 31, 2021	Sep. 20, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jul. 31, 2021
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--01-31
Entity File Number	000-50071
Entity Registrant Name	LIBERTY STAR URANIUM & METALS CORP.
Entity Central Index Key	0001172178
Entity Tax Identification Number	90-0175540
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2 East Congress Street Ste. 900
Entity Address, City or Town	Tucson
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85701
City Area Code	520
Local Phone Number	425-1433
Title of 12(b) Security	Common
Trading Symbol	LBSR
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		10,150,635

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jul. 31, 2021	Jan. 31, 2021
Current:
Cash and cash equivalents	$ 71,913	$ 6,718
Prepaid expenses	7,404	4,815
Total current assets	79,317	11,533
Property and equipment, net	30,639	33,556
Total assets	109,956	45,089
Liabilities and Stockholders’ Deficit
Accounts payable and accrued liabilities	475,794	467,957
Accounts payable to related parties	51,119	51,119
Accrued wages to related parties	811,711	811,711
Advances from related party	314,742	301,077
Notes payable to related parties	304,446	283,271
Convertible promissory note, net of unamortized debt discount of $4,547 and $7,642	113,696	87,969
Total current liabilities	2,071,508	2,003,104
Long-term:
Long-term accounts payable, net of current portion	6,300	20,300
Long-term debt - SBA	66,408	33,162
Total long-term liabilities	72,708	53,462
Total liabilities	2,144,216	2,056,566
Commitments and Contingencies (Note 10)
Stockholders’ deficit:
Common stock value	102	99
Common stock to be issued		15,000
Additional paid-in capital	55,710,395	55,503,564
Accumulated deficit	(57,744,758)	(57,530,141)
Total stockholders’ deficit	(2,034,260)	(2,011,477)
Total liabilities and stockholders’ deficit	109,956	45,089
Common Class A [Member]
Stockholders’ deficit:
Common stock value	$ 1	$ 1

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jul. 31, 2021	Jan. 31, 2021
Convertible promissory note, debt discount	$ 4,547	$ 7,642
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	24,800,000	24,800,000
Common stock, shares issued	10,150,635	9,902,052
Common stock, shares outstanding	10,150,635	9,902,052
Common Class A [Member]
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	200,000	0
Common stock, shares issued	102,000
Common stock, shares outstanding	102,000

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Income Statement [Abstract]
Revenues
Expenses:
Geological and geophysical costs	4,802	51,593	6,561	54,551
Salaries and benefits	37,197	33,971	73,756	71,721
Public relations	4,533		4,533
Depreciation	1,459	1,673	2,917	3,347
Legal	6,504	44,936	26,451	95,472
Professional services	23,745	23,477	44,082	43,433
General and administrative	24,902	13,704	38,294	33,665
Travel			640	439
Net operating expenses	103,142	169,354	197,234	302,628
Loss from operations	(103,142)	(169,354)	(197,234)	(302,628)
Other income (expense):
Interest expense	(56,189)	(61,199)	(94,373)	(166,702)
Gain (loss) on change in fair value of derivative liability	26,338	(94,667)	76,990	(39,631)
Total other income (expense)	(29,851)	(155,866)	(17,383)	(206,333)
Net loss	$ (132,993)	$ (325,220)	$ (214,617)	$ (508,961)
Net loss per share of common stock - basic and diluted	$ (0.01)	$ (0.03)	$ (0.02)	$ (0.05)
Weighted average number of shares of common stock outstanding - basic and diluted	10,244,049	9,769,606	10,144,455	9,488,417

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Class A Common Stock [Member]	Common Stock [Member]	Common Stock To Be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jan. 31, 2020		$ 91		$ 55,074,257	$ (56,780,396)	$ (1,706,048)
Beginning Balance, shares at Jan. 31, 2020		9,116,725
Issuance of common stock and warrants in private placement		$ 1		20,598		20,599
Issuance of common stock and warrants in private placement, shares		54,000
Shares issued for conversion of notes		$ 4		106,796		106,800
Shares issued for conversion of notes, shares		390,481
Reclass of APIC to derivative liabilities for tainted warrants				(189,472)		(189,472)
Resolution of derivative liabilities due to debt conversions				106,514		106,514
Net loss					(508,961)	(508,961)
Ending balance, value at Apr. 30, 2020		$ 96		55,118,693	(57,289,357)	(2,170,568)
Ending Balance, shares at Apr. 30, 2020		9,561,206
Beginning balance, value at Jan. 31, 2020		$ 91		55,074,257	(56,780,396)	(1,706,048)
Beginning Balance, shares at Jan. 31, 2020		9,116,725
Net loss						(508,961)
Ending balance, value at Jul. 31, 2020	$ 1	$ 99		55,543,400	(57,614,577)	(2,071,078)
Ending Balance, shares at Jul. 31, 2020	102,000	9,899,644
Beginning balance, value at Apr. 30, 2020		$ 96		55,118,693	(57,289,357)	(2,170,568)
Beginning Balance, shares at Apr. 30, 2020		9,561,206
Class A Shares issued to settle related party advances and notes payable	$ 1			49,061		49,062
Class A Shares issued to settle related party advances and notes payable, shares	102,000
Shares issued for conversion of notes		$ 2		63,058		63,060
Shares issued for conversion of notes, shares		195,581
Shares issued for services		$ 1		49,999		49,999
Shares issued for services, shares		142,857
Resolution of derivative liabilities due to debt conversions				262,589		262,589
Net loss					(325,220)	(325,220)
Ending balance, value at Jul. 31, 2020	$ 1	$ 99		55,543,400	(57,614,577)	(2,071,078)
Ending Balance, shares at Jul. 31, 2020	102,000	9,899,644
Beginning balance, value at Jan. 31, 2021	$ 1	$ 99	15,000	55,503,564	(57,530,141)	(2,011,477)
Beginning Balance, shares at Jan. 31, 2021	102,000	9,902,052
Issuance of common stock and warrants in private placement		$ 1	(15,000)	122,099		107,100
Issuance of common stock and warrants in private placement, shares		116,230
Shares issued for conversion of notes		$ 1		26,999		27,000
Shares issued for conversion of notes, shares		33,881
Reclass of APIC to derivative liabilities for tainted warrants				(293,528)		(293,528)
Resolution of derivative liabilities due to debt conversions				17,406		17,406
Net loss					(81,624)	(81,624)
Ending balance, value at Apr. 30, 2021	$ 1	$ 101		55,376,540	(57,611,765)	(2,235,123)
Ending Balance, shares at Apr. 30, 2021	102,000	10,052,163
Beginning balance, value at Jan. 31, 2021	$ 1	$ 99	15,000	55,503,564	(57,530,141)	(2,011,477)
Beginning Balance, shares at Jan. 31, 2021	102,000	9,902,052
Net loss						(214,617)
Ending balance, value at Jul. 31, 2021	$ 1	$ 102		55,710,395	(57,744,758)	(2,034,260)
Ending Balance, shares at Jul. 31, 2021	102,000	10,150,635
Beginning balance, value at Apr. 30, 2021	$ 1	$ 101		55,376,540	(57,611,765)	(2,235,123)
Beginning Balance, shares at Apr. 30, 2021	102,000	10,052,163
Shares issued for conversion of notes		$ 1		69,899		69,900
Shares issued for conversion of notes, shares		98,472
Resolution of derivative liabilities due to debt conversions				263,956		263,956
Net loss					(132,993)	(132,993)
Ending balance, value at Jul. 31, 2021	$ 1	$ 102		$ 55,710,395	$ (57,744,758)	$ (2,034,260)
Ending Balance, shares at Jul. 31, 2021	102,000	10,150,635

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Cash flows from operating activities:
Net loss	$ (214,617)	$ (508,961)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	2,917	3,347
Amortization of debt discounts	73,551	155,364
Expenses paid by related parties	22,376	89,958
Gain (loss) on change in fair value of derivative liabilities	(76,990)	39,631
Common shares issued for third party services		50,000
Changes in assets and liabilities:
Prepaid expenses	(2,589)	(1,177)
Accounts payable and accrued expenses	(6,162)	(3,423)
Accrued interest	17,112	11,151
Cash flows used in operating activities:	(184,402)	(164,110)
Cash flows from financing activities:
Proceeds from notes payable	32,497	62,974
Cash advance from related party		10,000
Proceeds from notes payable, related parties		55,000
Proceeds from convertible promissory notes	110,000
Proceeds from the issuance of common stock and warrants	105,000	20,599
Proceeds from exercise of warrants	2,100
Net cash provided by financing activities	249,597	148,573
Increase in cash and cash equivalents	65,195	(15,537)
Cash and cash equivalents, beginning of period	6,718	25,024
Cash and cash equivalents, end of period	71,913	9,487
Supplemental disclosure of cash flow information:
Income tax paid
Interest paid
Supplemental disclosure of non-cash items:
Resolution of derivative liabilities due to debt conversions and untainted warrants	281,361	369,103
Reclass of APIC to derivative liabilities for tainted warrants	293,528	189,472
Debt discounts due to derivative liabilities	64,823	140,000
Common stock issued for conversion of debt and interest	96,900	169,860
Class A Common Stock issued for conversion of related party advances and notes payable		49,062
Expenses paid by related party on behalf of the Company	$ 22,376	$ 89,958

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jul. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	NOTE 1 – Basis of Presentation The condensed consolidated financial statements included herein have been prepared by Liberty Star Uranium & Metals Corp. (the “Company”, “we”, “our”) without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and should be read in conjunction with our annual report on Form 10-K for the year ended January 31, 2021 as filed with the SEC under the Securities and Exchange Act of 1934 (the “Exchange Act”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, as permitted by the SEC, although we believe the disclosures which are made are adequate to make the information presented not misleading. The condensed consolidated financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position at July 31, 2021 and the results of our operations and cash flows for the periods presented. Interim results are subject to significant seasonal variations and the results of operations for the three and six months ended July 31,2021 are not necessarily indicative of the results to be expected for the full year. Reverse Stock Split On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021, and the Company’s common stock began trading on a split-adjusted basis on February 25, 2021. Prior to the effective date of the Certificate of Change, the Company was authorized to issue 6,150,000,000 12,300,000 Prior to the effective date of the Certificate of Change, the Company was authorized to issue 100,000,000 200,000 51,000,000 All references to common shares and common share data in these condensed consolidated financial statements and elsewhere in this Form 10-Q reflect the Reverse Stock Split.

Going concern

Going concern	6 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going concern	NOTE 2 – Going concern The Company has incurred losses from operations and requires additional funds for further exploratory activity and to maintain its claims prior to attaining a revenue generating status. There are no assurances that a commercially viable mineral deposit exists on any of our properties. In addition, the Company may not find sufficient ore reserves to be commercially mined. As such, there is substantial doubt about the Company’s ability to continue as a going concern. Management is working to secure additional funds through the exercise of stock warrants already outstanding, equity financings, debt financings or joint venture agreements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3 – Summary of Significant Accounting Policies Fair Value ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. Schedule of Fair Value of Financial Instruments Fair value measurements at reporting date using: Description Fair Value Quoted prices in Significant Significant Warrant and convertible note derivative liability at July 31, 2021 $ - - - $ - Warrant and convertible note derivative liability at January 31, 2021 $ - - - $ - Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liability. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liability, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liability are reported in other income (expense) as gain (loss) on change in fair value of derivative liability.

Related party transactions

Related party transactions	6 Months Ended
	Jul. 31, 2021
Related Party Transactions [Abstract]
Related party transactions	NOTE 4 – Related party transactions Our CEO, Brett Gross, was elected as President and Chief Executive Officer on December 7, 2018, and received no compensation for these services during the three and six months ended July 31,2021 and 2020. Advances From October 2019 through July 31, 2021, our CEO, Brett Gross, made various payments on behalf of the Company totaling $ 161,977 , and advanced the Company $ 62,000 in cash, all of which are reflected as advances from related party on the accompanying condensed consolidated balance sheets. The total advances were $ 314,742 and $ 301,077 as of July 31, 2021 and January 31, 2021, respectively, bear no interest and have no specified repayment date. Notes Payable During the six months ended July 31, 2021, the note principal increased $ 5,000 291,577 July 31, 2021 The Company has a note payable of $ 10,000 September 17, 2019 10 As of July 31, and January 31, 2021, the total balance of all related party notes payable above was $ 304,446 and $ 283,271 , respectively, which includes accrued interest of $ 48,533 and $ 36,070 , respectively. Accrued Wages As of July 31, and January 31, 2021, we had a balance of accrued unpaid wages of $ 759,949 to James Briscoe, our former Chairman of the Board, CEO, Chief Geologist, Secretary, Treasurer, and President. Additionally, we had a balance of accrued unpaid wages of $ 15,625 to a former President and $ 36,137 to Patricia Madaris, VP Finance & CFO. Accounts Payable As of July 31, and January 31, 2021, we had an aggregate balance due of approximately $ 167,000 on credit cards guaranteed by James Briscoe reflected in accounts payable and accrued liabilities on the accompanying condensed consolidated balance sheets. As of July 31, and January 31, 2021, we had accounts payable to JABA (controlled by James Briscoe) of $ 34,798 , which is reflected as accounts payable to related party on the accompanying condensed consolidated balance sheets. As of July 31, and January 31, 2021, we had a balance of $ 16,321 due to the spouse of James Briscoe.

Stock options

Stock options	6 Months Ended
	Jul. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock options	NOTE 5 – Stock options Qualified and Non-qualified incentive stock options outstanding at July 31, 2021 are as follows: Schedule of Stock Options Activity Weighted Number of exercise options price per share Outstanding, January 31, 2021 146,000 $ 3.019 Granted - - Expired - - Exercised - - Outstanding, July 31, 2021 146,000 $ 3.019 Exercisable, July 31, 2021 146,000 $ 3.019 These options had a weighted average remaining life of 7.12 0 During the six months ended July 31, 2021 and 2020, we recognized $ 0 0

Warrants

Warrants	6 Months Ended
	Jul. 31, 2021
Warrants
Warrants	NOTE 6 – Warrants As of July 31, 2021, there were 449,281 1.97 2.101 40,619 Stock warrants outstanding at July 31, 2021 are as follows: Schedule of Stock Warrants Outstanding Weighted average Number of warrants exercise Outstanding, January 31, 2021 400,166 $ 2.155 Issued 55,115 1.524 Expired - - Exercised (6,000 ) 0.350 Outstanding, July 31, 2021 449,281 $ 2.101 Exercisable, July 31, 2021 449,281 $ 2.101 During the six months ended July 31, 2021, the Company issued 55,115 three 1.426 1.646 As of June 17, 2021, the Company extended all warrants issued by the Company which expired or will expire during the year 2021. These warrants are extended for an additional three years. All other terms of the warrants remain unchanged, including application of the reverse split effective on February 25, 2021.

Derivative Liabilities

Derivative Liabilities	6 Months Ended
	Jul. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	NOTE 7 – Derivative Liabilities The embedded conversion feature in the convertible debt instruments that the Company issued (See Note 8), that became convertible during the six months ended July 31, 2021, qualified it as a derivative instrument since the number of shares issuable under the note is indeterminate based on guidance in FASB ASC 815, Derivatives and Hedging. These convertible notes tainted all other equity linked instruments including outstanding warrants and fixed rate convertible debt on the date that the instrument became convertible. The valuation of the derivative liability of the warrants was determined through the use of a Monte Carlo options model that values the liability of the warrants based on a risk-neutral valuation where the price of the option is its discounted expected value. The technique applied generates a large number of possible (but random) price paths for the underlying common stock via simulation, and then calculates the associated exercise value (i.e. “payoff”) of the option for each path. These payoffs are then averaged and discounted to a current valuation date resulting in the fair value of the option. The valuation of the derivative liability attached to the convertible debt was arrived at through the use of a Monte Carlo model that values the derivative liability within the notes. The technique applied generates a large number of possible (but random) price paths for the underlying (or underlyings) via simulation, and then calculates the associated payment value (cash, stock, or warrants) of the derivative features. The price of the underlying common stock is modeled such that it follows a geometric Brownian motion with constant drift, and elastic volatility (increasing as stock price decreases). The stock price is determined by a random sampling from a normal distribution. Since the underlying random process is the same, for enough price paths, the value of the derivative is derived from path dependent scenarios and outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion features with the reset provisions, the call/redemption/prepayment options, and the default provisions. Based on these features, there are six primary events that can occur; payments are made in cash; payments are made with stock; the note holder converts upon receiving a redemption notice; the note holder converts the note; the issuer redeems the note; or the Company defaults on the note. The model simulates the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, conversion price, etc.). Probabilities were assigned to each variable such as redemption likelihood, default likelihood, and timing and pricing of reset events over the remaining term of the notes based on management projections. This led to a cash flow simulation over the life of the note. A discounted cash flow for each simulation was completed, and it was compared to the discounted cash flow of the note without the embedded features, thus determining a value for the derivative liability. Key inputs and assumptions used to value the convertible note when it became convertible and upon settlement, and warrants upon tainting, were as follows: ● The stock projections are based on the historical volatilities for each date. These volatilities were in the 59.6 202.9 ● An event of default would not occur during the remaining term of the note; ● Conversion of the notes to stock would be completed monthly after any holding period and would be limited based on: 5% of the last 6 months average trading volume and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month. ● The effective discount was determined based on the historical trading history of the Company based on the specific pricing mechanism in each note; ● The Company would not have funds available to redeem the notes during the remaining term of the convertible notes; ● Discount rates were based on risk free rates in effect based on the remaining term and date of each valuation and instrument. ● The Holder would exercise the warrant at maturity if the stock price was above the exercise price; ● The Holder would exercise the warrant after any holding period prior to maturity at target prices starting at 2 times the exercise price for the Warrants or higher subject to monthly limits of: 5% of the last 6 months average trading volume increasing by 1% per month and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month. Using the results from the model, the Company recorded a derivative liability during the six months ended July 31,2021 of $ 293,528 64,823 0 64,823 64,823 0 During the six months ended July 31,2021, the Company recorded a reclassification from derivative liability to equity of $ 0 281,361 76,990 During the six months ended July 31, 2020, the Company recorded a reclassification from derivative liability to equity of $ 189,518 179,585 39,631 The Company did not have a derivative liability as of July 31, 2001, or January 31, 2021, since outstanding convertible notes were not convertible at period end or were fully converted during the period and consequently, the outstanding warrants were no longer tainted. The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liability: Schedule of Changes in Fair Value of Derivative Liabilities Six months ended July 31, 2021 2020 Beginning balance $ - $ - Total (gain) loss (76,990 ) 39,631 Settlements (281,361 ) (369,103 ) Additions recognized as debt discount 64,823 140,000 Additions due to tainted warrants 293,528 189,472 Ending balance $ - $ - Change in unrealized (gain) loss included in earnings relating to derivatives $ (76,990 ) $ 39,631

Long-term debt and convertible

Long-term debt and convertible promissory notes	6 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Long-term debt and convertible promissory notes	NOTE 8 – Long-term debt and convertible promissory notes Following is a summary of convertible promissory notes: Summary of Convertible Promissory Notes July 31, 2021 January 31, 2021 8 October 2020 September 2021 $ - $ 95,611 8 April 2021 April 2022 64,325 - 8 May 2021 May 2022 53,918 - Convertible note payable 118,243 95,611 Less debt discount (4,547 ) (7,642 ) Less current portion of convertible notes (113,696 ) (87,969 ) Long-term convertible notes payable $ - $ - On October 28, 2020, we received net proceeds of $ 82,000 8 8,500 3,000 September 1, 2021 180 75 10 96,900 132,353 0 On April 26, 2021, we received net proceeds of $ 60,000 8 3,000 April 23, 2022 180 75 10 On May 11, 2021, we issued a convertible note in the aggregate principal amount of $ 53,000 8 3,000 May 11, 2022 180 75 10 During the six months ended July 31, 2021 and 2020, the Company recorded debt discounts of $ 64,823 140,000 6,000 0 73,551 155,364 Notes Payable On June 22, 2020, the Company received loan proceeds of $ 32,300 100 3.75 30 158 June 18, 2021 June 18, 2023 On February 16, 2021, the Company received loan proceeds of $ 32,497 1 5 December 16, 2021 The balance of these two notes total $ 66,408 1,511

Stockholders_ deficit

Stockholders’ deficit	6 Months Ended
	Jul. 31, 2021
Equity [Abstract]
Stockholders’ deficit	NOTE 9 – Stockholders’ deficit Common Stock Our undesignated common shares are all of the same class, are voting and entitle stockholders to receive dividends as defined. Upon liquidation or wind-up, stockholders are entitled to participate equally with respect to any distribution of net assets or any dividends that may be declared. On March 5, 2021, the Company issued 6,000 2,100 0.35 On March 26, 2021, the Company issued 17,006 8,503 20,000 1.176 three 1.646 In March 2021, the Company issued 49,412 24,706 55,000 1.113 three 1.558 On April 2, 2021, the Company issued 9,818 4,909 10,000 1.019 three 1.426 On April 23, 2021, the Company issued 15,049 12,000 0.797 On April 27, 2021, the Company issued 18,832 15,000 0.797 On April 30, 2021, the Company received proceeds of $ 20,000 19,268 9,634 1.038 three 1.453 In May 2021, the Company issued a total of 98,472 69,900 0.699 0.743 Reverse Stock Split On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021, and the Company’s common stock began trading on a split-adjusted basis on February 25, 2021. Prior to the effective date of the Certificate of Change, the Company was authorized to issue 6,150,000,000 12,300,000 Prior to the effective date of the Certificate of Change, the Company was authorized to issue 100,000,000 200,000 102,000 2,408 All references to common shares and common share data in these unaudited condensed consolidated financial statements and elsewhere in this Form 10-Q as of July 31, 2021, and for the three and six months ended July 31, 2021, and 2020, reflect the Reverse Stock Split.

Commitments and contingencies

Commitments and contingencies	6 Months Ended
	Jul. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	NOTE 10 – Commitments and contingencies Legal Matter On August 22, 2019 (and amended on December 23, 2019), the Company filed a complaint with the Superior Court of Arizona (Case No. C20194139), demanding the titles and possession of certain vehicles and equipment of the Company from our former CEO, as well as seeking recovery of damages from the former CEO in an amount of not less than $ 50,000 . None of the vehicles and equipment, individually or in total, have any material net book value (being fully depreciated) as of July 31, 2021, or January 31, 2021. The matter is ongoing as of the date of this filing. On February 18, 2020, our former CEO and his spouse (the “Counterclaimants”) filed a First Amended Answer: First Amended Complaint and Counterclaim with the Superior Court of Arizona seeking dismissal of the Company’s complaint and reimbursement of Counterclaimants’ attorney fees incurred related to the matter. Additionally, the counterclaim alleges breach of contract by the Company and requests reimbursement of amounts loaned to the Company by our former CEO and his spouse, along with reimbursement of attorney fees. The Company believes these counterclaims are without merit and is aggressively defending them and believes no unfavorable outcome or material effect on our condensed consolidated financial statements will result.

Subsequent events

Subsequent events	6 Months Ended
	Jul. 31, 2021
Subsequent Events [Abstract]
Subsequent events	NOTE 11 – Subsequent events OTCQB Venture Market On August 6, 2021, the Company announced the OTC Markets Group Inc. approved the Company to trade as LBSR on the OTCQB Venture Market, designed for developing and entrepreneurial companies in the U.S. and abroad. Trading on the OTCQB began August 06, 2021. Authorized Shares Amendment On August 10, 2021, the Company’s Board of Directors (the “Board”) unanimously approved, and recommended for shareholder approval, the Amendment in order to increase the number of authorized shares of the Company’s common stock. The record date established by the Board for purposes of determining the number of outstanding shares of voting stock entitled to vote on the Amendment was August 11, 2021 (the “Record Date”). The Company currently has a total of 12,300,000 200,000 12,300,000 24,800,000 200,000 Pursuant to NRS 78.390, amendments to the Company’s Articles of Incorporation must be approved by a majority of the Company’s stockholders. In order to obtain stockholder approval for the Amendment, we could have convened a special meeting of the stockholders for the specific purpose of voting on such matter. However, NRS 78.320(2) provides than any action required or permitted to be taken at a meeting of the stockholders may be taken without a meeting if, before or after the action, a written consent thereto is signed by stockholders holding at least a majority of the voting power. In order to eliminate the costs and management time involved in holding a meeting and obtaining proxies and in order to effect the Amendment as early as possible in order to accomplish the purposes of the Amendment, the Board elected to utilize the written consent option of the holders of a majority of the outstanding shares of our common stock, as provided by Nevada law. The Company has two classes of stock authorized, Class A Stock and Common Stock. As of the Record Date, the Company had 10,150,635 102,000 Each share of Common Stock is entitled to 1 vote each share of Class A Stock is entitled to 200 votes 66.77 Pursuant to the rules and regulations promulgated by the SEC under the Exchange Act, an Information Statement must be sent to the holders of voting stock who did not sign the Written Consent at least 20 days prior to the effective date of any corporate action taken or authorized pursuant to the consent of the Company’s stockholders. These Information Statements were sent by the Company on September 10, 2021. Purchase Agreement with Triton Funds LP On August 20, 2021, the Company executed a $ 1,000,000 1,000,000 1,000,000 It may require Triton to purchase not less than $ 25,000 250,000 5 years 1,000,000 20,000,000 The Registration Statement was declared effective by the Securities and Exchange Commission on September 13, 2021. On September 14, 2021, the Company issued a total of 490,196 250,000 0.51

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2021
Accounting Policies [Abstract]
Fair Value	Fair Value ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. Schedule of Fair Value of Financial Instruments Fair value measurements at reporting date using: Description Fair Value Quoted prices in Significant Significant Warrant and convertible note derivative liability at July 31, 2021 $ - - - $ - Warrant and convertible note derivative liability at January 31, 2021 $ - - - $ - Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liability. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liability, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liability are reported in other income (expense) as gain (loss) on change in fair value of derivative liability.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jul. 31, 2021
Accounting Policies [Abstract]
Schedule of Fair Value of Financial Instruments	Schedule of Fair Value of Financial Instruments Fair value measurements at reporting date using: Description Fair Value Quoted prices in Significant Significant Warrant and convertible note derivative liability at July 31, 2021 $ - - - $ - Warrant and convertible note derivative liability at January 31, 2021 $ - - - $ -

Stock options (Tables)

Stock options (Tables)	6 Months Ended
	Jul. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Stock Options Activity	Qualified and Non-qualified incentive stock options outstanding at July 31, 2021 are as follows: Schedule of Stock Options Activity Weighted Number of exercise options price per share Outstanding, January 31, 2021 146,000 $ 3.019 Granted - - Expired - - Exercised - - Outstanding, July 31, 2021 146,000 $ 3.019 Exercisable, July 31, 2021 146,000 $ 3.019

Warrants (Tables)

Warrants (Tables)	6 Months Ended
	Jul. 31, 2021
Warrants
Schedule of Stock Warrants Outstanding	Stock warrants outstanding at July 31, 2021 are as follows: Schedule of Stock Warrants Outstanding Weighted average Number of warrants exercise Outstanding, January 31, 2021 400,166 $ 2.155 Issued 55,115 1.524 Expired - - Exercised (6,000 ) 0.350 Outstanding, July 31, 2021 449,281 $ 2.101 Exercisable, July 31, 2021 449,281 $ 2.101

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	6 Months Ended
	Jul. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Changes in Fair Value of Derivative Liabilities	The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liability: Schedule of Changes in Fair Value of Derivative Liabilities Six months ended July 31, 2021 2020 Beginning balance $ - $ - Total (gain) loss (76,990 ) 39,631 Settlements (281,361 ) (369,103 ) Additions recognized as debt discount 64,823 140,000 Additions due to tainted warrants 293,528 189,472 Ending balance $ - $ - Change in unrealized (gain) loss included in earnings relating to derivatives $ (76,990 ) $ 39,631

Long-term debt and convertibl_2

Long-term debt and convertible promissory notes (Tables)	6 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Summary of Convertible Promissory Notes	Following is a summary of convertible promissory notes: Summary of Convertible Promissory Notes July 31, 2021 January 31, 2021 8 October 2020 September 2021 $ - $ 95,611 8 April 2021 April 2022 64,325 - 8 May 2021 May 2022 53,918 - Convertible note payable 118,243 95,611 Less debt discount (4,547 ) (7,642 ) Less current portion of convertible notes (113,696 ) (87,969 ) Long-term convertible notes payable $ - $ -

Basis of Presentation (Details

Basis of Presentation (Details Narrative) - shares	Nov. 24, 2020	Jul. 31, 2021	Feb. 24, 2021	Jan. 31, 2021	Nov. 23, 2020
Affiliate, Collateralized Security [Line Items]
Stockholders' Equity, Reverse Stock Split	On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”).	On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021, and the Company’s common stock began trading on a split-adjusted basis on February 25, 2021.
Common stock, shares authorized	12,300,000	24,800,000		24,800,000	6,150,000,000
Common stock, shares outstanding		10,150,635		9,902,052
Common Class A [Member]
Affiliate, Collateralized Security [Line Items]
Common stock, shares authorized	200,000	200,000		0	100,000,000
Common stock, shares outstanding	102,000	102,000	51,000,000

Schedule of Fair Value of Finan

Schedule of Fair Value of Financial Instruments (Details) - USD ($)	Jul. 31, 2021	Jan. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant and convertible note derivative liability
Fair Value, Inputs, Level 1 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant and convertible note derivative liability
Fair Value, Inputs, Level 2 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant and convertible note derivative liability
Fair Value, Inputs, Level 3 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant and convertible note derivative liability

Related party transactions (Det

Related party transactions (Details Narrative) - USD ($)	Jul. 31, 2021	Sep. 17, 2018	Jul. 31, 2021	Jan. 31, 2021
Related Party Transaction [Line Items]
Due to related party	$ 304,446		$ 304,446	$ 283,271
Due to Officers or Stockholders, Current	314,742		314,742	301,077
Notes payable to related party	304,446		304,446	283,271
Interest Payable	48,533		48,533	36,070
Employee-related Liabilities, Current	811,711		811,711	811,711
James Briscoe [Member]
Related Party Transaction [Line Items]
Debt instrument, maturity date		Sep. 17, 2019
Notes payable to related party		$ 10,000
Debt instrument, interest rate		10.00%
Employee-related Liabilities, Current				759,949
James Briscoe [Member] | Accounts Payable and Accrued Liabilities [Member]
Related Party Transaction [Line Items]
Due to related party				167,000
James Briscoe [Member] | Accounts Payable [Member]
Related Party Transaction [Line Items]
Due to related party				34,798
Former President [Member]
Related Party Transaction [Line Items]
Employee-related Liabilities, Current				15,625
Patricia Madaris, CFO [Member]
Related Party Transaction [Line Items]
Employee-related Liabilities, Current				36,137
Spouse of James Briscoe [Member]
Related Party Transaction [Line Items]
Due to related party				$ 16,321
CEO [Member]
Related Party Transaction [Line Items]
Due to related party	161,977		161,977
Due to Officers or Stockholders, Current	62,000		62,000
Director [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Increase in debt principal amount			5,000
Two Directors [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Due to related party	$ 291,577		$ 291,577
Debt instrument, maturity date	Jul. 31, 2021

Schedule of Stock Options Activ

Schedule of Stock Options Activity (Details)	6 Months Ended
	Jul. 31, 2021$ / sharesshares
Share-based Payment Arrangement [Abstract]
Number of options, Outstanding | shares	146,000
Weighted average exercise price per share, Outstanding | $ / shares	$ 3.019
Number of options, Granted | shares
Weighted average exercise price per share, Granted | $ / shares
Number of options, Expired | shares
Weighted average exercise price per share, Expired | $ / shares
Number of options, Exercised | shares
Weighted average exercise price per share, Exercised | $ / shares
Number of options, Outstanding | shares	146,000
Weighted average exercise price per share, Outstanding | $ / shares	$ 3.019
Number of options, Exercisable | shares	146,000
Weighted average exercise price per share, Exercisable | $ / shares	$ 3.019

Stock options (Details Narrativ

Stock options (Details Narrative) - USD ($)	6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Share-based Payment Arrangement [Abstract]
Weighted average remaining life, stock options	7 years 1 month 13 days
Stock options, aggregate intrinsic value	$ 0
Compensation expense	$ 0	$ 0

Schedule of Stock Warrants Outs

Schedule of Stock Warrants Outstanding (Details)	6 Months Ended
	Jul. 31, 2021$ / sharesshares
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Weighted average exercise price, Exercisable	$ 2.101
Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of warrants, Outstanding | shares	400,166
Weighted average exercise price, Outstanding	$ 2.155
Number of warrants, Issued | shares	55,115
Weighted average exercise price, Issued	$ 1.524
Number of warrants, Expired | shares
Weighted average exercise price, Expired
Number of warrants, Exercised | shares	(6,000)
Weighted average exercise price, Exercised	$ 0.350
Number of warrants, Outstanding | shares	449,281
Weighted average exercise price, Outstanding	$ 2.101
Number of warrants, Exercisable | shares	449,281
Weighted average exercise price, Exercisable	$ 2.101

Warrants (Details Narrative)

Warrants (Details Narrative) - USD ($)	Jul. 17, 2021	Jul. 31, 2021
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]
Share purchase warrants outstanding and exercisable		449,281
Warrants weighted average remaining life		1 year 11 months 19 days
Weighted average exercise price of warrant		$ 2.101
Weighted average intrinsic value for warrants outstanding		$ 40,619
Warrant [Member]
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]
Weighted average exercise price of warrant		$ 2.101
Warrant expiration term description	the Company extended all warrants issued by the Company which expired or will expire during the year 2021. These warrants are extended for an additional three years. All other terms of the warrants remain unchanged, including application of the reverse split effective on February 25, 2021.
Investor [Member]
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]
Number of warrants issued		55,115
Warrants terms		3 years
Investor [Member] | Minimum [Member]
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]
Warrant exercise price per share		$ 1.426
Investor [Member] | Maximum [Member]
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]
Warrant exercise price per share		$ 1.646

Schedule of Changes in Fair Val

Schedule of Changes in Fair Value of Derivative Liabilities (Details) - USD ($)	6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Beginning balance
Total (gains) loss	(76,990)	39,631
Settlements	(281,361)	(369,103)
Additions recognized as debt discount	64,823	140,000
Additions due to tainted warrants	293,528	189,472
Ending balance
Change in unrealized (gain) loss included in earnings relating to derivatives	$ (76,990)	$ 39,631

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative)	3 Months Ended		6 Months Ended
	Jul. 31, 2021USD ($)	Jul. 31, 2020USD ($)	Jul. 31, 2021USD ($)	Jul. 31, 2020USD ($)
Derivative [Line Items]
Unamortized debt discount	$ 6,000	$ 0	$ 6,000	$ 0
Gain (loss) on derivative liability	26,338	$ (94,667)	$ 76,990	(39,631)
Derivative Liability [Member]
Derivative [Line Items]
Conversion note description			Conversion of the notes to stock would be completed monthly after any holding period and would be limited based on: 5% of the last 6 months average trading volume and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month.
Percentage of exercise price for warrant, description			The Holder would exercise the warrant after any holding period prior to maturity at target prices starting at 2 times the exercise price for the Warrants or higher subject to monthly limits of: 5% of the last 6 months average trading volume increasing by 1% per month and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month.
Derivative loss			$ 0
Amortization of debt discount			64,823
Interest expense			64,823
Unamortized debt discount	0		0
Reclassification of derivative liability to equity			0	189,518
Reclassification due to conversion of convertible notes			281,361	179,585
Gain (loss) on derivative liability			76,990	$ 39,631
Derivative Liability [Member] | Convertible Debt [Member]
Derivative [Line Items]
Derivative liabilities	64,823		64,823
Derivative Liability [Member] | Warrant [Member]
Derivative [Line Items]
Derivative liabilities	$ 293,528		$ 293,528
Measurement Input, Price Volatility [Member] | Minimum [Member]
Derivative [Line Items]
Fair value assumptions, measurement input, percentages	0.596		0.596
Measurement Input, Price Volatility [Member] | Maximum [Member]
Derivative [Line Items]
Fair value assumptions, measurement input, percentages	2.029		2.029

Summary of Convertible Promisso

Summary of Convertible Promissory Notes (Details) - USD ($)	Jul. 31, 2021	Jan. 31, 2021
Debt Instrument [Line Items]
Convertible note payable	$ 118,243	$ 95,611
Less debt discount	(4,547)	(7,642)
Less current portion of convertible notes	(113,696)	(87,969)
Long-term convertible notes payable
8% convertible note payable issued October 2020, due September 2021 [Member]
Debt Instrument [Line Items]
Convertible note payable		95,611
8% convertible note payable issued April 2021, due April 2022 [Member]
Debt Instrument [Line Items]
Convertible note payable	64,325
8% convertible note payable issued May 2021, due May 2022 [Member]
Debt Instrument [Line Items]
Convertible note payable	$ 53,918

Summary of Convertible Promis_2

Summary of Convertible Promissory Notes (Details) (Parenthetical)	6 Months Ended	12 Months Ended
	Jul. 31, 2021	Jan. 31, 2021
8% convertible note payable issued October 2020, due September 2021 [Member]
Debt Instrument [Line Items]
Convertible notes payable, interest rate	8.00%	8.00%
Debt issuance date	Oct. 31, 2020	Oct. 31, 2020
Due date	Sep. 30, 2021	Sep. 30, 2021
8% convertible note payable issued April 2021, due April 2022 [Member]
Debt Instrument [Line Items]
Convertible notes payable, interest rate	8.00%	8.00%
Debt issuance date	Apr. 30, 2021	Apr. 30, 2021
Due date	Apr. 30, 2022	Apr. 30, 2022
8% convertible note payable issued May 2021, due May 2022 [Member]
Debt Instrument [Line Items]
Convertible notes payable, interest rate	8.00%
Debt issuance date	May 31, 2021	May 31, 2021
Due date	May 31, 2022	May 31, 2022

Long-term debt and convertibl_3

Long-term debt and convertible promissory notes (Details Narrative)

May 11, 2021USD ($)IntegerTradingDays

Apr. 27, 2021USD ($)shares

Apr. 26, 2021USD ($)IntegerTradingDays

Apr. 23, 2021USD ($)shares

Feb. 16, 2021USD ($)

Oct. 28, 2020USD ($)IntegerTradingDays

Jun. 22, 2020USD ($)

May 31, 2021USD ($)shares

Jul. 31, 2021USD ($)

Jul. 31, 2020USD ($)

Jul. 31, 2021USD ($)shares

Jul. 31, 2020USD ($)

Short-term Debt [Line Items]

Net proceeds from debt

$ 110,000

Original issue discount amount

$ 6,000

$ 0

6,000

0

Legal fees

6,504

$ 44,936

26,451

95,472

Debt discounts amount

64,823

140,000

Amortization of debt discount

73,551

$ 155,364

Debt including interest

66,408

Debt principal

1,511

SBA's Economic Injury Disaster Loan Program [Member]

Short-term Debt [Line Items]

Debt instrument, maturity date

Jun. 18, 2021

Proceeds from loan

$ 32,300

Loan fee

$ 100

Loan, interest rate

3.75%

Debt term

30 years

Loan installment due amount

$ 158

SBA's Economic Injury Disaster Loan Program [Member] | Extended Maturity [Member]

Short-term Debt [Line Items]

Debt instrument, maturity date

Jun. 18, 2023

PPP Loan [Member]

Short-term Debt [Line Items]

Debt instrument, maturity date

Dec. 16, 2021

Proceeds from loan

$ 32,497

Loan, interest rate

1.00%

Debt term

5 years

October 2020 Note [Member]

Short-term Debt [Line Items]

Net proceeds from debt

$ 82,000

Debt instrument, interest rate

8.00%

Original issue discount amount

$ 8,500

Legal fees

$ 3,000

Debt instrument, maturity date

Sep. 1, 2021

Debt instrument convertible consecutive trading days | Integer

180

Common stock conversion price per share

75.00%

Debt instrument, convertible, threshold trading days | TradingDays

10

Debt instrument conversion, amount

$ 15,000

$ 12,000

$ 69,900

$ 96,900

Debt conversion on convertible shares | shares

18,832

15,049

98,472

132,353

Principal and interest total amount

$ 0

$ 0

April 2021 Note [Member]

Short-term Debt [Line Items]

Net proceeds from debt

$ 60,000

Debt instrument, interest rate

8.00%

Legal fees

$ 3,000

Debt instrument, maturity date

Apr. 23, 2022

Debt instrument convertible consecutive trading days | Integer

180

Common stock conversion price per share

75.00%

Debt instrument, convertible, threshold trading days | TradingDays

10

May 2021 Note [Member]

Short-term Debt [Line Items]

Debt instrument, interest rate

8.00%

Legal fees

$ 3,000

Debt instrument, maturity date

May 11, 2022

Debt instrument convertible consecutive trading days | Integer

180

Common stock conversion price per share

75.00%

Debt instrument, convertible, threshold trading days | TradingDays

10

Debt instrument, face value

$ 53,000

Stockholders_ deficit (Details

Stockholders’ deficit (Details Narrative) - USD ($)

Apr. 27, 2021

Apr. 23, 2021

Apr. 02, 2021

Mar. 26, 2021

Mar. 05, 2021

Nov. 24, 2020

May 31, 2021

Apr. 30, 2021

Mar. 31, 2021

Jul. 31, 2021

Feb. 24, 2021

Jan. 31, 2021

Nov. 23, 2020

Accumulated Other Comprehensive Income (Loss) [Line Items]

Stockholders' Equity, Reverse Stock Split

On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”).

On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021, and the Company’s common stock began trading on a split-adjusted basis on February 25, 2021.

Common stock, shares authorized

12,300,000

24,800,000

24,800,000

6,150,000,000

Common stock, shares outstanding

10,150,635

9,902,052

Common Class A [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Common stock, shares authorized

200,000

200,000

0

100,000,000

Common stock, shares outstanding

102,000

102,000

51,000,000

Number of shares rounded due to reverse stock split

2,408

October 2020 Note [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued price per unit

$ 0.797

$ 0.797

$ 1.038

Proceeds from issuance of common stock and warrants

$ 20,000

Warrants term

3 years

Warrant exercise price per share

$ 1.453

Debt conversion of convertible shares

18,832

15,049

98,472

132,353

Debt instrument conversion, amount

$ 15,000

$ 12,000

$ 69,900

$ 96,900

October 2020 Note [Member] | Minimum [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued price per unit

$ 0.699

October 2020 Note [Member] | Maximum [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares issued price per unit

$ 0.743

Common Stock [Member] | October 2020 Note [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of common stock shares issued

19,268

Warrant [Member] | October 2020 Note [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of common stock shares issued

9,634

CEO [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of common stock shares issued

17,006

Shares issued price per unit

$ 1.176

Warrants purchase

8,503

Proceeds from issuance of common stock and warrants

$ 20,000

Warrants term

3 years

Warrant exercise price per share

$ 1.646

CEO [Member] | Common Stock [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of common stock shares issued

49,412

Shares issued price per unit

$ 1.113

Warrants purchase

24,706

Proceeds from issuance of common stock and warrants

$ 55,000

Warrants term

3 years

Warrant exercise price per share

$ 1.558

Accredited Investor [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of common stock shares issued

9,818

6,000

Proceeds from issuance of warrants

$ 2,100

Shares issued price per unit

$ 1.019

$ 0.35

Warrants purchase

4,909

Proceeds from issuance of common stock and warrants

$ 10,000

Warrants term

3 years

Warrant exercise price per share

$ 1.426

Commitments and contingencies (

Commitments and contingencies (Details Narrative)	Aug. 22, 2019USD ($)
Former Chief Executive Officer [Member]
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Loss Contingency, Damages Sought, Value	$ 50,000

Subsequent events (Details Narr

Subsequent events (Details Narrative) - USD ($)	Sep. 14, 2021	Aug. 20, 2021	Aug. 11, 2021	Aug. 10, 2021	Jul. 31, 2021	Feb. 24, 2021	Jan. 31, 2021	Nov. 24, 2020	Nov. 23, 2020
Subsequent Event [Line Items]
Common stock, shares authorized					24,800,000		24,800,000	12,300,000	6,150,000,000
Common stock, shares issued					10,150,635		9,902,052
Common stock, shares outstanding					10,150,635		9,902,052
Common Class A [Member]
Subsequent Event [Line Items]
Common stock, shares authorized					200,000		0	200,000	100,000,000
Common stock, shares issued					102,000
Common stock, shares outstanding					102,000	51,000,000		102,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock, shares authorized			24,800,000	12,300,000
Common stock, shares issued			10,150,635
Common stock, shares outstanding			10,150,635
Voting rights			Each share of Common Stock is entitled to 1 vote
Subsequent Event [Member] | Purchase Agreement [Member]
Subsequent Event [Line Items]
Number of common stock shares issued	490,196
Stock Issued During Period, Value, New Issues	$ 250,000
Shares Issued, Price Per Share	$ 0.51
Subsequent Event [Member] | Common Stock [Member] | Purchase Agreement [Member] | Triton Funds LP [Member]
Subsequent Event [Line Items]
Stock available for purchase to related party		$ 1,000,000
Purchase condition		It may require Triton to purchase not less than $25,000 or more than $250,000 per month of its common stock at a purchase price equal to 75% of the lowest daily volume-weighted average price of the Company’s common stock during the 5 business days immediately prior to the date of closing of each separate purchase installment.
Purchase right term		5 years
Additional shares available for purchase to related party		$ 1,000,000
Market capitalization amount of outstanding shares		20,000,000
Subsequent Event [Member] | Common Stock [Member] | Purchase Agreement [Member] | Triton Funds LP [Member] | Minimum [Member]
Subsequent Event [Line Items]
Purchase limit per month		25,000
Subsequent Event [Member] | Common Stock [Member] | Purchase Agreement [Member] | Triton Funds LP [Member] | Maximum [Member]
Subsequent Event [Line Items]
Purchase limit per month		250,000
Subsequent Event [Member] | Warrant [Member] | Warrant Agreement [Member] | Triton Funds LP [Member]
Subsequent Event [Line Items]
Stock available for purchase to related party		$ 1,000,000
Purchase right term		5 years
Subsequent Event [Member] | Common Class A [Member]
Subsequent Event [Line Items]
Common stock, shares authorized			200,000
Common stock, shares issued			102,000
Common stock, shares outstanding			102,000
Voting rights			each share of Class A Stock is entitled to 200 votes
Voting rights percentage of issued and outstanding shares			66.77%